Innate Pharma SA
IPHAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Innate Pharma SA Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Innate Pharma SA — 20-F filed Apr 24, 2020
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 9 annual periods. The latest annual period ends Dec 31, 2025. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| RHUMBLINE ADVISERS | 2026-03-31 | 4,734 | Not shown | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 10 | Not shown | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 2 | Not shown | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 10,064 | Not shown | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 43,365 | Not shown | SEC filing |
| UBS Group AG | 2026-03-31 | 861 | Not shown | SEC filing |
| GAMMA Investing LLC | 2026-03-31 | 240 | Not shown | SEC filing |
| Lion Point Capital, LP | 2026-03-31 | 81,151 | Not shown | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 43,524 | Not shown | SEC filing |
| JANE STREET GROUP, LLC | 2025-12-31 | 92,753 | Not shown | SEC filing |
| BARCLAYS PLC | 2025-12-31 | 1 | Not shown | SEC filing |
| MORGAN STANLEY | 2025-12-31 | 46,394 | Not shown | SEC filing |
| OLD MISSION CAPITAL LLC | 2025-12-31 | 28,431 | Not shown | SEC filing |
| Farther Finance Advisors, LLC | 2025-12-31 | 10 | Not shown | SEC filing |
| GAMMA Investing LLC | 2025-12-31 | 1,073 | Not shown | SEC filing |
| MORGAN STANLEY | 2025-12-31 | 46,394 | Not shown | SEC filing |
| Lion Point Capital, LP | 2025-12-31 | 81,151 | Not shown | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2025-12-31 | 20,308 | Not shown | SEC filing |
| UBS Group AG | 2025-12-31 | 947 | Not shown | SEC filing |
| RHUMBLINE ADVISERS | 2025-12-31 | 5,204 | Not shown | SEC filing |
- Each value is checked against Innate Pharma SA's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Lion Point Capital, LP: 81,151 shares reported 2025-12-31; 81,151 shares reported 2026-03-31.
- GAMMA Investing LLC: 1,073 shares reported 2025-12-31; 240 shares reported 2026-03-31.
- UBS Group AG: 947 shares reported 2025-12-31; 861 shares reported 2026-03-31.
- JANE STREET GROUP, LLC: 92,753 shares reported 2025-12-31; 43,365 shares reported 2026-03-31.
- MILLENNIUM MANAGEMENT LLC: 20,308 shares reported 2025-12-31; 10,064 shares reported 2026-03-31.
- Farther Finance Advisors, LLC: 10 shares reported 2025-12-31; 10 shares reported 2026-03-31.
- RHUMBLINE ADVISERS: 5,204 shares reported 2025-12-31; 4,734 shares reported 2026-03-31.
- GAMMA Investing LLC: 2,281 shares reported 2025-09-30; 1,073 shares reported 2025-12-31.
- UBS Group AG: 4,797 shares reported 2025-09-30; 947 shares reported 2025-12-31.
- MILLENNIUM MANAGEMENT LLC: 11,661 shares reported 2025-06-30; 20,308 shares reported 2025-12-31.
- Farther Finance Advisors, LLC: 10 shares reported 2025-09-30; 10 shares reported 2025-12-31.
- RHUMBLINE ADVISERS: 470 shares reported 2025-09-30; 5,204 shares reported 2025-12-31.
Showing the 12 most recent filer reports.
5 filers have only one report here.
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.